IBM Watson Health Reports Real-World Progress of AI in Oncology in #ASCO2019

Shots:

• IBM Watson has presented 22 new scientific studies showing progress in clinical studies of cancer using AI-Technology with informed decisions based on curated scientific evidences, insights and information which are unidentified manually and further leading to QoL
• The presented data includes: Watson For Oncology lead to 13.6% changes in informs clinical decision reviewed by multidisciplinary tumor board; Watson For Genomics Surfaces resulted in new insights for oncologists to treat hematological malignancies; Watson For Oncology improves cancer patient confidence
• Additionally, IBM Watson reported to identify automatically, high-quality and relevant scientific publications with the help of machine learning on words from abstracts of papers cited at three expert resources: NCCN, NCI-PDQ, and Hemonc.org further resulting in 93% accuracy, 95% sensitivity, and 91% specificity of treatment

Click here to read full press release/ article | Ref: IBM | Image: Japan Times